Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yee

Showing results (1-10 of 506) with videos related to

Pageof 51
Sort By:
Missouri Dental Journal (Jefferson City, Mo.)|September 1, 1989
Sketches of a dental mercy missionS Yee
Pharmaceutical Research|June 1, 1997
In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or mythS Yee
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|July 4, 2003
UnfoldingKristen S Yee
Cancer Biology & Therapy|May 26, 2011
Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targetingNelson S Yee
Journal of Clinical Medicine|August 14, 2020
Liquid Biopsy: A Biomarker-Driven Tool towards Precision OncologyNelson S Yee
Lab Animal|August 23, 2019
Conflicts of interest: Lack of policy and/or of common sense?Amy S Yee
Advances in Experimental Medicine and Biology|January 5, 2013
Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotypeNelson S Yee
Biomedicines|March 17, 2018
Update in Systemic and Targeted Therapies in Gastrointestinal OncologyNelson S Yee
Pharmaceuticals (Basel, Switzerland)|April 6, 2017
Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic TargetNelson S Yee
Current Molecular Pharmacology|July 17, 2015
Immunotherapeutic Approaches in Pancreatic Adenocarcinoma: Current Status and Future PerspectivesNelson S Yee
Pageof 51

Showing results (1-10 of 506) with videos related to

Sort By:
Pageof 51
Missouri Dental Journal (Jefferson City, Mo.)|September 1, 1989
Sketches of a dental mercy missionS Yee
Pharmaceutical Research|June 1, 1997
In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or mythS Yee
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|July 4, 2003
UnfoldingKristen S Yee
Cancer Biology & Therapy|May 26, 2011
Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targetingNelson S Yee
Journal of Clinical Medicine|August 14, 2020
Liquid Biopsy: A Biomarker-Driven Tool towards Precision OncologyNelson S Yee
Lab Animal|August 23, 2019
Conflicts of interest: Lack of policy and/or of common sense?Amy S Yee
Advances in Experimental Medicine and Biology|January 5, 2013
Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotypeNelson S Yee
Biomedicines|March 17, 2018
Update in Systemic and Targeted Therapies in Gastrointestinal OncologyNelson S Yee
Pharmaceuticals (Basel, Switzerland)|April 6, 2017
Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic TargetNelson S Yee
Current Molecular Pharmacology|July 17, 2015
Immunotherapeutic Approaches in Pancreatic Adenocarcinoma: Current Status and Future PerspectivesNelson S Yee
Pageof 51